Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 49:478-486, November-December
doi: 10.1176/appi.psy.49.6.478
© 2008 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Love, R. J.
* Articles by Carlos Poston, W. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Love, R. J.
* Articles by Carlos Poston, W. S.
Related Collections
* Other Patient Groups/Issues
* Depression
* Syndromes Secondary to General Medical Disorders
* Antidepressants

Impact of Antidepressant Use on Gastric Bypass Surgery Patients’ Weight Loss and Health-Related Quality-of-Life Outcomes

Robert J. Love, D.O., M.S., Ashley S. Love, Dr.P.H., M.P.H., M.S., Steven Bower, M.D., and Walker S. Carlos Poston, Ph.D., M.P.H.

Received October 29, 2006; revised March 28, 2007; accepted April 5, 2007. From Wilford Hall Medical Center and University of Texas Health Science Center at San Antonio, and the University of Missouri–Kansas City School of Medicine. Send correspondence and reprint requests to Dr. Robert J. Love, Psychiatry Resident, Department of Psychiatry, Wilford Hall Medical Center, University of Texas Health Science Center at San Antonio, San Antonio, TX 78249. e-mail: Robert.Love2{at}dover.af.mil
© 2008 The Academy of Psychosomatic Medicine

BACKGROUND: Psychological factors may be predictive of post-surgical adjustment and successful outcomes in obesity-surgery populations. OBJECTIVE: The authors compared post–gastric bypass surgery (GBS) outcomes of patients being given active psychotropic treatment for depression, with those of patients without treatment or identifiable need for treatment at enrollment. METHOD: Outcome measures included weight and repeated administration of the Medical Outcome Survey Short Form–36 (SF–36). RESULTS: There was no impact of antidepressant treatment on GBS patients’ weight loss or SF–36 outcomes. CONCLUSION: Therefore, patients with actively treated depression should be expected to have GBS outcomes equivalent to those of patients without identifiable psychiatric illness or treatment.







Get information about faster international access.

Privacy Policy

Copyright © 2008 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org